Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Tudorza

- PMLiVE

AZ’s new COPD therapy gets green light in Europe

EC backs Duaklir in chronic respiratory condition

EU flag

EMA backs 15 new medicines for use in EU

Includes new treatments from Gilead, Lilly, Boehringer, AstraZeneca and Janssen

- PMLiVE

Mixed messages for AZ’s benralizumab in COPD study

Respiratory hope misses primary goal in trial data presented at ERS congress

- PMLiVE

Boehringer’s Spiriva cleared for asthma in EU

Drug approved as a treatment for adults with severe asthma

- PMLiVE

GSK relaunches COPD website

Revamped online hub offers tools and guidance for those affected by respiratory condition

- PMLiVE

AstraZeneca signs $2bn deal to buy Almirall respiratory portfolio

Will boost its pipeline prospects and inhaled device capabilities

- PMLiVE

GSK trial throws everything at COPD

Tests combination of fluticasone furoate, umeclidinium and vilanterol

Boehringer Ingelheim headquarters

Boehringer submits COPD combo in EU

Combines Spiriva and Striverdi

AZ expands its mHealth services with new COPD initiative

Partners with Exco InTouch to launch Me&MyCOPD programme

- PMLiVE

Novartis, Boehringer stake claims to combination COPD market

Includes combination follow-up to Spiriva

- PMLiVE

GSK clear to launch COPD hope Anoro in Europe

Strengthens respiratory platform ahead of patent expiry for Advair/Seretide

- PMLiVE

GSK’s COPD drug Incruse cleared in Europe

Medicine is GSK’s first long-acting muscarinic antagonist

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links